Past Webinars

Introducing ARCALYST (rilonacept) - The first and only FDA-approved therapy that treats recurrent pericarditis and reduces the risk of future flares

 

 

Speakers:

  • Dr. Martin LeWinter, Cardiologist at University of Vermont Medical Center
  • Dana Martin, Senior Vice President of Global Medical Affairs and Patient Advocacy at Kiniksa Pharmaceuticals
  • April Scott, Senior Director of Patient Services at Kiniksa Pharmaceuticals

About Webinar:

Join Dr. Martin LeWinter, Cardiologist at University of Vermont Medical Center, to learn about a new treatment option for recurrent pericarditis. 

April Scott, Senior Director of Patient Services at Kiniksa Pharmaceuticals will introduce Kiniksa OneConnect, a patient support program designed to provide you with personalized support through your treatment journey. 

During this educational webinar you will learn about:

  • Recurrent pericarditis
  • Treatment with ARCALYST 
  • Support services offered by Kiniksa OneConnect